Results 11 to 20 of about 44,634 (268)
Immuno-stimulation by OX40 ligand transgenic Ewing sarcoma cells [PDF]
Frontiers in Oncology, 2015 Interleukin-2 (IL-2) transgenic Ewing sarcoma cells can induce tumor specific T and NK cell responses and reduce tumor growth in vivo and in vitro. Nevertheless, the efficiency of this stimulation is not high enough to inhibit tumor growth completely. In
Dajana eReuter +3 more
doaj +7 more sources
Increased risk for other cancers in individuals with Ewing sarcoma and their relatives [PDF]
Cancer Medicine, 2019 Background There are few reports of the association of other cancers with Ewing sarcoma in patients and their relatives. We use a resource combining statewide genealogy and cancer reporting to provide unbiased risks. Methods Using a combined genealogy of
Diana Abbott +9 more
doaj +2 more sources
Ewing sarcoma with very late metastasis in the skull: a case report
Journal of Medical Case Reports, 2022 Background Ewing sarcoma is a malignant bone tumor; however, its prognosis has improved since the development of modern chemotherapy. Although Ewing sarcoma outcomes have improved, issues related to late complications, secondary malignant neoplasms, and ...
Ryota Hagihara +6 more
doaj +1 more source
18F-fluorodeoxyglucose positron emission tomography / computed tomography in primary Ewing sarcoma of the lung [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2022 Introduction. Ewing sarcoma is rare in medical practice, and evaluating positron emission tomography / computed tomography (PET/CT) imaging of soft tissue Ewing sarcoma is a challenge. Primary Ewing sarcoma of the lung is an infrequent diagnosis.
Zivgarević Ljiljana, Žunić Svetlana
doaj +1 more source
Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes. [PDF]
PLoS ONE, 2015 Ewing Sarcoma is an aggressive malignancy of bone and soft tissue affecting children and young adults. Ewing Sarcoma is driven by EWS/Ets fusion oncoproteins, which cause widespread alterations in gene expression in the cell.
Brian F Niemeyer +5 more
doaj +1 more source
Ewing sarcoma of the pelvis: Clinical features and overall survival,
Cancer Treatment and Research Communications, 2022 Introduction: Primary Ewing Sarcoma of Bone is a malignancy whose treatment requires both systemic chemotherapy and local control through surgical resection and/or radiation. Ewing Sarcoma of the pelvis has been noted to confer a worse prognosis relative
Jeffrey Mark Brown +4 more
doaj +1 more source
Primary Ewing Sarcoma of Sphenoid Bone with Intracranial Extension: A Common Tumour at an Uncommon Location [PDF]
Journal of Clinical and Diagnostic Research, 2017 Primary Ewing Sarcoma of the cranial bone is rare, contributing to only 1% of all Ewing Sarcomas. Primary cranial Ewing Sarcoma occurs most commonly in temporal bone followed by parietal and occipital bones. Sphenoid bone is less commonly involved.
Guddi Rani Singh +2 more
doaj +1 more source
Frontiers in Genetics, 2022 Background: The molecular mechanisms of EWS-FLI-mediating target genes and downstream pathways may provide a new way in the targeted therapy of Ewing sarcoma.
Runzhi Huang +17 more
doaj +1 more source
Oman Journal of Ophthalmology, 2022 Ewing sarcoma is one of the rare, highly malignant neuroectodermal tumors frequently involving bones. Primary orbital Ewing sarcoma is extremely uncommon.
Teena Mariet Mendonca +5 more
doaj +1 more source
BMC Cancer, 2020 Background The treatment of Ewing sarcoma, an aggressive bone and soft tissue sarcoma, is associated with suboptimal outcomes and significant side-effects.
Torin Waters +4 more
doaj +1 more source